Limited treatment with β-1,3/1,6-glucan improves production values of broiler chickens challenged with Escherichia coli

Poultry Science

Volumn 85, Issue 4, 2006, Pages 613-618

  Huff, G R ^a   Huff, W E ^a   Rath, N C ^a   Tellez, G ^b  

^a UNIVERSITY OF ARKANSAS   (United States)

^b NONE

Author keywords

Antibiotic alternative; Colibacillosis; Immune modulation; Yeast cell wall; glucan

Indexed keywords

AVES; BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; GALLUS GALLUS; SACCHAROMYCES CEREVISIAE;

EPIGLUCAN; GLUCAN;

ANIMAL; ANIMAL DISEASE; ARTICLE; BIRD DISEASE; CHICKEN; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENTEROBACTER INFECTION; FEMALE; MALE; MICROBIOLOGY; RANDOMIZED CONTROLLED TRIAL;

ANIMALS; CHICKENS; ESCHERICHIA COLI INFECTIONS; FEMALE; GLUCANS; MALE; POULTRY DISEASES;

EID: 33646929807     PISSN: 00325791     EISSN: 15253171     Source Type: Journal    
DOI: 10.1093/ps/85.4.613     Document Type: Article

References (28)

1. Bahl, A. K., and N. Sorgente. 2002. Immustim®, a nutricine biomodulator: Controlling necrotic enteritis without growth promotion antibiotics: Afield evaluation. Poult. Sci. 80(Suppl 1):116. (Abstr.)
2. Barnes, H. J., J. P. Vaillancourt, and W. B. Gross. 2003. Colibacillosis. Pages 631-656 in Diseases of Poultry. 11th ed. Y. M. Saif, ed. Iowa State Press, Ames, IA.
3. Bohn, J. A., and J. N. BeMiller. 1995. (1-3)-β-D-Glucans as biological response modifiers: A review of structure-functional activity relationships. Carbohydr. Polymers 28:3-14.
4. Chang, C. F., H. Y. Chen, M. S. Su, and I. C. Liao. 2000. Immunomodulation by dietary beta 1, 3-glucan in the brooders of the black tiger shrimp Penaeus monodon. Fish Shellfish Immunol. 10:505-514.
5. Cleary, J. A., G. E. Kelly, and A. J. Husband. 1999. The effect of molecular weight and beta-1,6-linkages on priming of macrophage function in mice by (1,3)-beta-D-glucan. Immunol. Cell Biol. 77:395-403.
6. Dibner, J. J., and J. D. Richards. 2005. Antibiotic growth promoters in agriculture. History and mode of action. Poult. Sci. 84:634-643.
7. Dritz, S. S., J. Shi, T. L. Kielian, R. D. Goodband, J. L. Nelssen, M. D. Tokach, M. M. Chengappa, J. E. Smith, and F. Blecha. 1995. Influence of dietary β-glucan on growth performance, nonspecific immunity, and resistance to Streptococcus suis infection in weanling pigs. J. Anim. Sci. 73:3341-3350.
8. Gersema, L. M., and D. K. Helling. 1986. The use of subtherapeutic antibiotics in animal feed and its implications on human health. Drug Intell. Clin. Pharm. 20:214-218.
9. Hiss, S., and H. Sauerwein. 2003. Influence of dietary β-glucan on growth performance, lymphocyte proliferation, specific immune response, and haptoglobin plasma concentration in pigs. J. Anim. Physiol. 87:2-11.
10. Huff, G. R., W. E. Huff, J. M. Balog, N. C. Rath, and A. K. Bahl. 2002. Effect of dietary treatment with β-1,3/1,6-glucan (Immustim®) on disease resistance of turkeys challenged with Escherichia coli. Poult. Sci. 80(Suppl. 1):18. (Abstr.)
11. Klasing, K. C., D. E. Laurin, R. K. Peng, and D. M. Fry. 1987. Immunologically mediated growth depression in chicks: In-fluence of feed intake, corticosterone and interleukin-1. J. Nutr. 117:1629-1637.
12. Lowry, V. K., M. B. Farnell, P. J. Ferro, C. L. Swaggerty, A. Bahl, and M. H. Kogut. 2005. Purified β-glucan as an abiotic feed additive up-regulates the innate immune response in immature chickens against Salmonella enterica serovar Enteritidis. Int. J. Food Microbiol. 98:309-318.
13. Mansell, P. W. A., G. Rowden, and C. Hammer. 1978. Clinical experiences with the use of glucan. In Immune Modulation and Control of Neoplasia by Adjuvant Therapy. Raven Press, New York, NY.
14. National Research Council. 1994. Nutrient Requirements of Poultry. Natl. Acad. Press, Washington, DC.
15. Piercy, D. W. T., and B. West. 1976. Experimental Escherichia coli infection in broiler chickens: Course of the disease induced by inoculation via the air sac route. J. Comp. Pathol. 86:203-210.
16. Plat, J., and R. P. Mensink. 2005. Food components and immune function. Curr. Opin. Lipidol. 16:31-37.
17. Reynolds, J. A., M. D. Kastello, D. G. Harrington, C. L. Crabbs, C. J. Peters, J. V. Jemski, G. H. Scott, and N. R. Di Luzio. 1980. Glucan-induced enhancement of host resistance to selected infectious diseases. Infect. Immun. 30:51-57.
18. Roura, E., J. Homedes, and K. C. Klasing. 1992. Prevention of immunologic stress contributes to the growth-promoting ability of dietary antibiotics in chicks. J. Nutr. 122:2283-2290.
19. Russell, S. M. 2003. The effect of airsacculitis on bird weights, uniformity, fecal contamination, processing errors, and populations of Campylobacter spp. and Escherichia coli. Poult. Sci. 82:1326-1331.
20. Sakurai, T., K. Hashimoto, I. Suzuki, N. Ohno, S. Oikawa, A. Masuda, and T. Yadomae. 1992. Enhancement of murine alveolar macrophage functions by orally administered β-glucan. Int. J. Immunopharmacol. 14:821-830.
21. SAS Institute. 1988. SAS/STAT User's Guide: 1988 ed. SAS Inst. Inc., Cary, NC.
22. Sheldon, B. C., and S. Verhulst. 1996. Ecological immunology: Costly parasite defenses and trade-offs in evolutionary ecology. Trend Ecol. Evol. 11:317-321.
23. Song, Y. L., J. J. Liu, L. C. Chan, and H. H. Sung. 1997. Glucan-induced disease resistance in tiger shrimp (Panaeus monodon). Fish Vaccinology Dev. Biol. Stand. 90:413-421.
24. Tzianabos, A. O. 2000. Polysaccharide immunomodulators as therapeutic agents: Structural aspects and biologic function. Clin. Microbiol. Rev. 13:523-533.
25. Vetvicka, V. 2001. β-Glucans as immunomodulators. JANA 31-34.
26. Williams, D. L., and N. R. Di Luzio. 1979. Glucan induced modification of experimental Staphylococcus aureus infection in normal, leukemic, and immunosuppressed mice. Adv. Exp. Med. Biol. 121:291-306.
27. Young, S. H., J. Ye, D. G. Frazer, X. Shi, and V. Castranova. 2001. Molecular mechanism of tumor necrosis factor-alpha production in 1-3-β-glucan (zymosan)-activated macrophages. J. Biol. Chem. 276:20781-20787.
28. Yun, C. H., A. Estrada, A. VanKessel, B. C. Park, and B. Laarveld. 2003. Beta-glucan, extracted from oat, enhances disease resistance against bacterial and parasitic infections. FEMS Immunol. Med. Microbiol. 35:67-75.